B. Kaboudin, S. Alipour / Tetrahedron Letters 50 (2009) 4243–4245
4245
Sons: New York, 1976; p 1; (h) Kaboudin, B. Phosphorus, Sulfur Silicon 2002, 177,
1749–1751; (i) Bhagat, S.; Chakraborti, A. K. J. Org. Chem. 2007, 72, 1263–1270.
7. (a) Barycki, J.; Mastalerz, P.; Soroka, M. Tetrahedron Lett. 1970, 36, 3147–3150;
(b) Kaboudin, B.; Sorbiun, M. Tetrahedron Lett. 2007, 48, 9015–9017.
8. (a) Genet, J. P.; Uziel, J.; Port, M.; Touzin, A. M.; Roland, S.; Thorimbert, S.;
Tanier, S. Tetrahedron Lett. 1992, 33, 77–80; (b) Qian, C.; Huang, T. J. Org. Chem.
1998, 63, 4125–4128; (c) Ranu, B. C.; Hajira, A.; Jana, U. Org. Lett. 1999, 1, 1141–
1143; (d) Manabe, K.; Kobayashi, S. Chem. Commun. 2000, 669–670; (e)
Chandrasekhar, S.; Prakash, S. J.; Jagadeshwar, V.; Narsihmulu, C. Tetrahedron
Lett. 2001, 42, 5561–5563.
120 °C at ambient pressure in a microwave reactor (a Milestone, Micro SYNTH
Microwave Labstation for Synthesis, microwave reactor was used for all
experiments). The resulting mixture was subjected to column chromatography
on silica gel with EtOAc/n-hexane (9:1) and evaporation of the solvent under
reduced pressure gave pure products in 55–85% yields. All products gave
satisfactory spectral data in accord with the assigned structures and literature
reports (compounds 2a, 2e, 2f, and 2g).11,12 Analytical and spectral data for
compounds 2: Compound 2b: white solid, mp: 137–138 °C; 1H NMR
(CD3SOCD3—250 MHz), d: 1.05–1.23 (m, 12H), 3.91–4.18 (m, 8H), 4.53 (dt,
1H, JHP = 22.8 Hz, J = 10.5 Hz), 5.97 (d, 1H, NH, J = 10.5 Hz), 6.90 (d, 2H,
J = 8.8 Hz), 7.06 (2H, J = 8.8 Hz). 31P NMR (CD3SOCD3—101.25 MHz), d: 18.36.
13C NMR (CD3SOCD3—62.9 MHz), d: 16.6 (d, JPC = 2.5 Hz), 48.8 (t,
JPC = 145.2 Hz), 62.7–63.2 (m), 114.9, 120.6, 128.6, 146.5 (t, JPC = 3.7 Hz). Anal.
Calcd for C15H26NO6P2Cl: C, 43.57; H, 6.29; N, 3.39. Found: C, 43.63; H, 6.20; N,
3.45. Compound 2c: white solid, mp: 70–71 °C; 1H NMR (CD3SOCD3—250 MHz),
d: 1.05–1.25 (m, 12H), 2.13 (s, 3H), 3.90–4.13 (m, 8H), 4.42 (dt, 1H,
JHP = 22.8 Hz, J = 10.5 Hz), 5.42 (d, 1H, NH, J = 10.5 Hz), 6.76 (d, 2H, J = 8.2 Hz),
6.87 (2H, J = 8 Hz). 31P NMR (CD3SOCD3—101.25 MHz), d: 18.69. 13C NMR
(CD3SOCD3—62.9 MHz), d: 16.5 (d, JPC = 2.5 Hz), 20.4, 49.1 (t, JPC = 145.9 Hz),
62.8–63.4 (m), 113.6, 126.1, 129.5, 144.9 (t, JPC = 4.4 Hz). Anal. Calcd for
C16H29NO6P2: C, 48.84; H, 7.43; N, 3.56. Found: C, 48.61; H, 7.55; N, 3.50.
Compound 2d: white solid, mp: 139–140 °C; 1H NMR (CD3SOCD3—250 MHz), d:
1.03–1.30 (m, 12H), 3.89–4.18 (m, 8H), 4.53 (dt, 1H, JHP = 22.8 Hz, J = 10.5 Hz),
6.00 (d, 1H, NH, J = 10.5 Hz), 6.86 (d, 2H, J = 8.5 Hz), 7.17 (2H, J = 8.5 Hz). 31P
NMR (CD3SOCD3—101.25 MHz), d: 18.31. 13C NMR (CD3SOCD3—62.9 MHz), d:
16.1 (d, JPC = 1.8 Hz), 48.7 (t, JPC = 145.2 Hz), 62.7–63.2 (m), 108.0, 115.5, 131.4,
146.9 (t, JPC = 3.7 Hz). Anal. Calcd for C15H26NO6P2Br: C, 39.38; H, 5.73; N, 3.06.
Found: C, 39.15; H, 5.70; N, 2.93. Compound 2h: colorless oil; 1H NMR
(CD3SOCD3–TMS, 250 MHz), d: 1.02–1.25 (m, 15H), 2.40 (q, 2H, J = 7.5 Hz),
3.90–4.18 (m, 8H), 4.71 (dt, 1H, JHP = 22 Hz, J = 10.25 Hz), 6.64 (t, 1H, J = 7.5 Hz),
7.85–7.08 (m, 3H). 31P NMR (CD3SOCD3–TMS, 101.25 MHz), d: 18.70. 13C NMR
(CD3SOCD3–TMS, 62.9 MHz), d: 13.5, 16.4–16.6 (m), 23.8, 49.1 (t,
JPC = 144.6 Hz), 62.6–63.2 (m), 112.0, 118.3, 127.1, 128.0, 128.5, 143.8 (t,
JPC = 4.4 Hz). Anal. Calcd for C17H31NO6P2: C, 50.10; H, 7.67; N, 3.44. Found: C,
49.95; H, 7.55; N, 3.52. Compound 2i: colorless oil; 1H NMR (CD3SOCD3—
250 MHz), d: 1.03–1.24 (m, 12H), 3.98–4.17 (m, 8H), 5.36 (dt, 1H,
JHP = 21.75 Hz, J = 10.5 Hz), 7.53 (d, 1H, J = 9.25 Hz), 7.56 (dd, 1H, J = 9.25 Hz,
J = 2.5 Hz), 8.08 (d, 1H, J = 2.5 Hz), 8.27 (d, 1H, NH, J = 7.5 Hz). 31P NMR
(CD3SOCD3—101.25 MHz), d: 16.75. 13C NMR (CD3SOCD3—62.9 MHz), d: 16.3–
16.7 (m), 48.1 (t, JPC = 143.4 Hz), 62.5, 118.5, 120.8, 125.3, 132.6, 136.6, 143.0 (t,
J = 5.03 Hz). Anal. Calcd for C15H25N2O8P2Cl: C, 39.29; H, 5.50; N, 6.11. Found:
C, 39.11; H, 5.67; N, 6.05. Compound 2j: white solid, mp: 63–64 °C; 1H NMR
(CD3SOCD3–TMS, 250 MHz), d: 1.01–1.28 (m, 12H), 3.90–4.21 (m, 8H), 4.83 (dt,
1H, JHP = 22.5 Hz, J = 10 Hz), 5.34 (d, 1H, NH, J = 9.5 Hz), 6.98 (d, 1H, J = 7 Hz),
7.17–7.60 (m, 4H), 7.72–7.85 (m, 1H), 7.95–8.09 (m, 1H). 31P NMR (CD3SOCD3–
TMS, 101.25 MHz), d: 18.55. 13C NMR (CD3SOCD3–TMS, 62.9 MHz), d: 16.3, 49.1
(t, JPC = 146.5 Hz), 63.5–64.0 (m), 106.3, 118.5, 120.6, 123.4, 125.5, 126.3, 126.7,
128.7, 134.2, 141.5. Anal. Calcd for C19H29NO6P2: C, 53.13; H, 6.81; N, 3.26.
Found: C, 52.95; H, 6.63; N, 3.10. Compound 2m: white solid, mp: 81–82 °C; 1H
NMR (CD3SOCD3—250 MHz), d: 1.03–1.25 (m, 12H), 3.92–4.24 (m, 8H), 4.44
(dt, 1H, JHP = 22.5 Hz, J = 10.5 Hz), 5.37 (d, 1H, NH, J = 10.5 Hz), 6.62 (t, 1H,
J = 7.5 Hz), 6.77–6.95 (m, 6H,), 7.09 (t, 2H, J = 8.25 Hz), 7.57 (s, NH, 1H). 31P
NMR (CD3SOCD3—101.25 MHz), d: 18.77. 13C NMR (CD3SOCD3—62.9 MHz), d:
16.4, 49.6 (t, JPC = 145.9 Hz), 63.3–63.7 (m), 114.5, 114.6, 118.2, 121.5, 129.4,
133.9, 141.9 (t, JPC = 4.3 Hz), 146.0. Anal. Calcd for C21H32N2O6P2: C, 53.60; H,
6.86; N, 5.96. Found: C, 53.51; H, 6.74; N, 5.86.
9. Abdou, W. M.; Shaddy, A. A. Arkivoc 2009, ix, 143–182.
10. (a) Gittens, S. A.; Bansal, G.; Zernicke, R. F.; Uludag˘, H. Adv. Drug. Delivery Rev.
2005, 57, 1011–1036; (b) Kavanagh, K. L.; Guo, K.; Dunford, J. E.; Wu, X.; Knapp,
S.; Ebetino, F. H.; Rogers, M. J.; Russel, R. G. G.; Opermann, U. Proc. Natl. Acad.
Sci. U.S.A. 2006, 103, 7829–7834; (c) Sanders, J. M.; Gómez, A. O.; Mao, J.;
Meints, G. A.; Van Brussel, E. M.; Burzynska, A.; Kafarski, P.; Gonzáles-
Pacanowska, D.; Oldfield, E. J. Med. Chem. 2003, 46, 5171–5183; (d) Martin, M.
B.; Grimley, J. S.; Lewis, J. C.; Heath, H. T., III; Bailey, B. N.; Kendrick, H.; Yardley,
V.; Caldera, A.; Lira, R.; Urbina, J. A.; Moreno, S. N.; Docampo, R.; Croft, S. L.;
Oldfield, E. J. Med. Chem. 2001, 44, 909–916.
11. Kotsikorou, E.; Song, Y.; Chan, J. M. W.; Faelens, S.; Tovian, Z.; Broderick, E.;
Bakarala, N.; Docampo, R.; Oldfield, E. J. Med. Chem. 2005, 48, 6128–6139.
12. Lecerclé, D.; Gabillet, S.; Gomis, J.-M.; Taran, F. Tetrahedron Lett. 2008, 49,
2083–2087.
13. Pudovik, A. N.; Konovalova, I. V. Synthesis 1979, 81–96.
14. (a) Maier, L. Phosphorus, Sulfur 1981, 11, 311–322; (b) Takeuchi, M.; Sakamoto,
S.; Yoshida, M.; Abe, T.; Isomura, Y. Chem. Pharm. Bull. 1993, 41, 688–693; c
Soloducho, J.; Gancarz, R.; Wieczorek, P.; Korf, J.; Hafner, J.; Lejczak, B.;
Kafarski, P. Patent PL93-298436 93408, 1993; Chem Abstr. 1998, 128, 61631.
15. (a) Prishchenko, A. A.; Livantsov, M. V.; Petrosyan, V. S. Zh. Obshch. Kim. 1993,
63, 1902. Chem. Abstr. 1994, 120, 217906; (b) Wu, M.; Chen, R.; Huang, Y. Synth.
Commun. 2004, 34, 1393–1398.
16. Yokomatsu, T.; Yoshida, Y.; Nakabayashi, N.; Shibuya, S. J. Org. Chem. 1994, 59,
7562–7564.
17. Krutikov, V. I.; Erkin, A. V.; Pautov, P. A.; Zolotukhina, M. M. Russ. J. Gen. Chem.
2003, 73, 187.
18. (a) Kappe, C. O. Angew. Chem., Int. Ed. 2004, 43, 6250–6284; (b) Loupy, A.;
Perreux, L. Tetrahedron 2001, 57, 9199–9223; (c) Kaboudin, B.; Nazari, R.
Tetrahedron Lett. 2001, 42, 8211; (d) Kaboudin, B. Tetrahedron Lett. 2002, 43,
8713–8714; (e) Kaboudin, B. Tetrahedron Lett. 2003, 44, 1051–1053; (f)
Kaboudin, B.; Haghighat, H.; Yokomatsu, T. J. Org. Chem. 2006, 71, 6604–6606.
19. (a) Kaboudin, B. Chem. Lett. 2001, 880–881; (b) Kaboudin, B.; Nazari, R. Synth.
Commun. 2001, 31, 2245–2250; (c) Kaboudin, B.; Rahmani, A. Synthesis 2003,
2705–2708; (d) Kaboudin, B.; Saadati, F. Synthesis 2004, 1249–1252; (e)
Kaboudin, B.; Rahmani, A. Org. Prep. Proced. Int. 2004, 36, 82–86; (f) Kaboudin,
B.; Moradi, K. Tetrahedron Lett. 2005, 46, 2989–2991; (g) Kaboudin, B.;
Haghighat, H. Tetrahedron Lett. 2005, 46, 7955–7957; (h) Kaboudin, B.;
Karimi, M. Bioorg. Med. Chem. Lett. 2006, 16, 5324–5327; (i) Kaboudin, B.;
Moradi, K. Synthesis 2006, 2339–2342; (j) Kaboudin, B.; Jafari, E. Synthesis 2006,
3063–3066; (k) Kaboudin, B.; Farjadian, F. Beilstein J. Org. Chem. 2006, 2, 4; (l)
Yamagishi, T.; Kusano, T.; Kaboudin, B.; Yokomatsu, T.; Sakuma, C.; Shibuya, S.
Tetrahedron 2003, 59, 767–772; (m) Kaboudin, B.; Haruki, T.; Yamaghishi, T.;
Yokomatsu, T. Tetrahedron 2007, 63, 8199–8205; (n) Kaboudin, B.; Haruki, T.;
Yamagishi, T.; Yokomatsu, T. Synthesis 2007, 3226–3232; (o) Kaboudin, B.;
Haghighat, H.; Yokomatsu, T. Tetrahedron: Asymmetry 2008, 19, 862–866.
20. Diethyl phosphite (15 mmol) was added to a mixture of amine (5 mmol) and
triethyl orthoformate (5 mmol) and the solution was stirred for 30–80 min at